InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: stoneroad post# 111490

Wednesday, 02/13/2013 9:29:57 AM

Wednesday, February 13, 2013 9:29:57 AM

Post# of 345971
No, I still think the randomized, double-blinded, single-arm, 3 mg/kg arm will be very good. I still hope the
first-line is good too, but this just reduces the overall impact. The package won't look as good now. The reality
is that other drugs have failed against pancreatic cancer, like Avastin, but been approved for other indications.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News